 .      
 


    
     ,  ( )          .

   , , ,   , , - , ,    ?  ,         .     ,   ,        .

       ,      ( ,   ,    ,   ,    ,    蠖     ).

     ,      ,     ,       21-     .   , ,  ,    ,   ,  ,  .



  :

   ,       .

,    .

   .





    

 .     



   



  .

               .



2022 byDavid Perlmutter, MD

This edition published byarrangement with Little, Brown andCompany, NewYork, NewYork, USA. All rights reserved.

  , , . Π,  , 2023


* * *


      ,         .



Ƞ  ,                  .        


  ,    .        ,   .       ,   ,  .      ,  ,  ..,    .      ,  ,           .




.  


   .

 .   

         1960-    ,    . ,    ,    .         ,         . ,            ,       .    ,         . :      .      .

 2020.,     COVID-19,   ,     : TheDrive   [1 -     ,  -,         ,  .   ,           .    ,    .        .    ,  ,   DrPerlmutter.com (http://drperlmutter.com/),         .Peterattiamd.com (http://peterattiamd.com/).].       ,     ,  .   ,    ,    .   () ,    ,   -  ,      ,       .      ,       ,   .         ,     (,    ).         .        .     ,    . Ƞ             젖   ,    , , - ,     .

       .      ,         .  -,  ,    ,  ,     .       ,       ,    ,  ,    .       ,       .

:   , , ,    , ,  , ,  ,   ,  ?

:    [2 -          ,              . ..].

           ,  . ,  ,     , ?             ,     ?    ,       ( ,          1219    )?[3 - Centers forDisease Control andPrevention (cdc.gov (http://cdc.gov/)); American Heart Association (heart.org (http://heart.org/)).]    ,    74%   ,     ,  ,     ?[4 - Hidden inPlain Sight // SugarScience, University ofCalifornia atSan Francisco // sugarscience.ucsf.edu/hidden-in-plain-sight/ (http://sugarscience.ucsf.edu/hidden-in-plain-sight/).]

   .

        , ,   , ,     ,     .   ,      ,    .  ࠖ     ,    ,  젖   .  ,   ,    ,     (     ).          ,       .      ,   .         .       ,      ,     . Ƞ  ,     ,   ,   , ,  . Ƞ,    .

       ,    .  -     .            .


 

                , , , , , ,  ,  , , , , -  .   ,   1892.,     1898. JAMA    [5 - Haig A. Uric Acid asa Factor inthe Causation ofDisease: AContribution tothe Pathology ofHigh Arterial Tension, Headache, Epilepsy, Mental Depression, Paroxysmal H?moglobinuria andAn?mia, Brights Disease, Diabetes, Gout, Rheumatism, andOther Disorders. London: Franklin Classics, 2018. . Haig A. Uric Acid asa Factor inthe Causation ofDisease AContribution tothe Pathology ofHigh Blood Pressure, Headache, Epilepsy, Mental Depression, Paroxysmal Hemoglobinuria andAnemia, Brights Disease, Gout, Rheumatism andother Disorders // JAMA. 1898. Vol.31. 3. P.139 // doi.org/10.1001/jama.1898.02450030041022 (http://doi.org/10.1001/jama.1898.02450030041022).].   ,    .      ,      .           , .   ,     ,     ,  .



     ,   ,      -    1200. .. (     [6 - Fragkou Th., Goula K., Drakoulogkona O. TheHistory ofGout Through Centuries // Nephrology Dialysis Transplantation. 2015. May. Vol.30. Suppl. 3. Pp. iii377iii380 // doi.org/10.1093/ndt/gfv186.05 (http://doi.org/10.1093/ndt/gfv186.05).];   ໠ gout   gutta,  []).     蠖    ,      [7 - Oxford English Dictionary, 2nd ed. Oxford, UK: Oxford University Press, 2004.].   ꠫ ,    .          . ,   II...,    ,     , - [8 - Nuki G., Simkin P. A. AConcise History ofGout andHyperuricemia andTheir Treatment // Arthritis Research & Therapy. 2006. Vol.8. Suppl. 1. P. S1 // doi.org/10.1186/ar1906 (http://doi.org/10.1186/ar1906).].


,     ,        ,    () ,    ,  . ,        .      ,  ⠖  :  ,  ,  VIII,  ,  ,  ,  ,   ,     .     ,       ,   .

Ѡ1960- 1990-          蠖    10 [9 - Maurer J. Early Gout IsBad forthe Heart: Recent Research Context // Med-Page Today, November28, 2019 // medpagetoday.com/reading-room/acrr/generalrheumatology/83581 (http://medpagetoday.com/reading-room/acrr/generalrheumatology/83581). . Li Y. etal. Clinical Characteristics ofEarly-Onset Gout inOutpatient Setting // ACR Open Rheumatology. 2019. Vol.1. 7. Pp. 397402 // doi.org/10.1002/acr2.11057 (http://doi.org/10.1002/acr2.11057).].         [10 - Singh J. A. Gout: Will theKing ofDiseases Be theFirst Rheumatic Disease toBe Cured? // BMC Medicine. 2016. Vol.14. P.180 // doi.org/10.1186/s12916-016-0732-1 (http://doi.org/10.1186/s12916-016-0732-1).]. ,       .       ,    (   ) :  ,  ,      (-,    ).

,        .  ,  21%    ,        [11 - George Ch., Minter D. A. Hyperuricemia // StatPearls. Treasure Island, FL: 2021 // ncbi.nlm.nih.gov/books/NBK459218/ (http://ncbi.nlm.nih.gov/books/NBK459218/).]. ,    . Ƞ     ,     . (        ,      ,   ,        .)  ,  ,     :  ,    ,   .  ,    ࠖ   ,  .   ,         .   ,         ,     ,       , ,  ,     ,        .  ,     ,    ,    . Ƞ   ,           ,     .

          :    ,        .      ,          ,   2- ,   ,  ..  ,          ,     . ,  ,          ,     .

         ,       . ,     ,  ,    - . Ƞ         ,   ,    ,    ,      .    ,     .  XX.  ,  -       ,      .  XXI.   ,         .     ,    ,       .      .     ,   .

ʠ,       :      ,      16%    39%  - [12 - Chen J.-H. etal. Serum Uric Acid Level asan Independent Risk Factor forAll-Cause, Cardiovascular, andIschemic Stroke Mortality: AChinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol.61. 2. Pp. 225232 // doi.org/10.1002/art.24164 (http://doi.org/10.1002/art.24164). . Prado de Oliveira E., Burini R. C. High Plasma Uric Acid Concentration: Causes andConsequences // Diabetology & Metabolic Syndrome. 2012. April. Vol.4. P.12 // doi.org/10.1186/1758-5996-4-12 (http://doi.org/10.1186/1758-5996-4-12).]. (    .)    2017.  :     [   ]           ,   2- ,   ,             ,          2- [13 - El Ridi R., Tallima H. Physiological Functions andPathogenic Potential ofUric Acid: AReview // Journal ofAdvanced Research. 2017. September. Vol.8. 5. Pp. 487493 // doi.org/10.1016/j.jare.2017.03.003 (http://doi.org/10.1016/j.jare.2017.03.003).].   ,    ࠖ         [14 - El Ridi andTallima, Physiological Functions andPathogenic Potential ofUric Acid.].   ࠖ ,     .       (    ),       .   ,     ,       2-  (, ),       堖 -    .

              ,    ,       . ,  [15 - DiNicolantonio J. J., OKeefe J. H., Lucan S. C. Added Fructose: APrincipal Driver ofType 2 Diabetes Mellitus andIts Consequences // Mayo Clinic Proceedings. 2015. March. Vol.90. 3. Pp. 372381 // doi.org/10.1016/j.mayocp.2014.12.019 (http://doi.org/10.1016/j.mayocp.2014.12.019).].       .      ,      ,     , , , ,   , ,  ,      . ,   ,        ,  ,         ,    .             ,    ,     .    TheLancet 1970-  ,  [16 - Stirpe F. etal. Fructose-induced Hyperuricaemia // TheLancet. 1970. December. Vol.296. 7686. Pp. 13101311 // doi.org/10.1016/s0140-6736(70)92269-5 (http://doi.org/10.1016/s0140-6736%2870%2992269-5).],          .

,        , .         ,    .           ,          頖  .    ,    ,      , ,      [17 - Goran M. I. etal. TheObesogenic Effect ofHigh Fructose Exposure During Early Development // Nature Reviews Endocrinology. 2013. August. Vol.9. 8. Pp. 494500.].           .

  ,     ,  ,  ,         , ,   ,   ,    .   ,       ,      ,   . -    (,    )  , ,   , ,    () ,     .   ,    ,     .  ,      ,     () ,      .

  ,   .         ,     ,   ,  ,  ,     .        ,       ,      ( ).   ,      ,   : ࠖ    [18 - Rivard Ch. etal. Sack andSugar, andthe Aetiology ofGout inEngland Between 1650 and1900 // Rheumatology. 2013. March. Vol.52. 3. Pp. 421426 // doi.org/10.1093/rheumatology/kes297 (http://doi.org/10.1093/rheumatology/kes297).].      ,     .                 .      , ,  ,    (,  ,  )    ,       [19 - Zgaga L. etal. TheAssociation ofDietary Intake ofPurine-Rich Vegetables, Sugar-Sweetened Beverages andDairy with Plasma Urate, ina Cross-Sectional Study // PLOS ONE. 2012. Vol.7. 6. P. e38123 // doi.org/10.1371/journal.pone.0038123 (http://doi.org/10.1371/journal.pone.0038123).].

     ,    .      ,        .        ,   , ,         [20 - Singh J. A., Reddy S. G., Kundukulam J. Risk Factors forGout andPrevention: ASystematic Review ofthe Literature // Current Opinion inRheumatology. 2011. March. Vol.23. 2. Pp. 192202 // doi.org/10.1097/BOR.0b013e3283438e13 (http://doi.org/10.1097/BOR.0b013e3283438e13).].    ,    ,       .

,        ,        .     , ,    蠖 , , , , ,   ,   ,           .  ,                .         . -,     . -,       . -,    ,     . Ƞ-,    ,      : , ,  Ѡ  (    ,     ).         :              ,  .  ,   ,   LUV[21 - LUV    love (). ..] (. lower uric values    ).        ,     ,    .

    ,              .   ,     ,   .       .   ,     :    ?   ,   :  , ,  ,    ?      ,         .           ,    .  ,    ,    , .


  

        ,   2005.           .    ,        .           .          . ,          ,    ,    ,     (  ).        ,     ,     , ,     .

        .    ,    ,     ,    . ( ,      ,   .)        ,    .  ,          ,          .   ,    ,    ,         .   ,    ,      ,  ,   ,        .

         ,   ,  ,  ,   .    ,                 ,  , , - ,     .     ,     ,  ,   ,   ,  .


: ʠ -[22 -  , ,     , . ..]   

,     ?      ,  ,     ,  ,  .       , , ,   ,   ,               .      ,   ,  ,          .

  .  ,      ,   .     ,          .  :        蠫,  堫.



1.    ().

2.   ,  ,     .

3.   ,   , ,  .

4.       , .

5.       .

6.    .

7.    .

8.   (, ) / -.

9.     (  ࠖ 30 ).

10.    .

11.   ( , , ).

12.  ,  ,   .

13.    (, , , )   .

14.      ,  , , , ,  ,  .

15.     ,  .

16.   /  .

17.     (, ,  2- ).

18.-       (,  ).

19.   .

20.    .



    ,     .    .     ,    ,     .

,   , ,   ,          .     ,  , ,             .    ,  ,    COVID-19,      1 (#g1),  ,  , ,   ,   .              ,      ,      .

        .     .   .  ,   ,     ,      .            (    A1c, HbA1c).      . , ,  ,    ,  ,  .  :        5,5%,      [23 - Enzinger Ch. etal. Risk Factors forProgression ofBrain Atrophy inAging: Six-Year Follow-Up ofNormal Subjects // Neurology. 2005. May24. Vol.64. 10. Pp. 17041711 // doi.org/10.1212/01.WNL.0000161871.83614.BB (http://doi.org/10.1212/01.WNL.0000161871.83614.BB).].     5,8/ ( ),     ,     [24 - Crane P. K. etal. Glucose Levels andRisk ofDementia // New England Journal ofMedicine. 2013. August. Vol.369. 6. Pp. 540548 // doi.org/10.1056/NEJMoa1215740 (http://doi.org/10.1056/NEJMoa1215740).]. ,         ,      :       .   ,    ,     .        .    .

  ,  ࠖ    .      ,      .      ,   , ,         ,      . ,  :  .    .  ,     ,         .    ,    .

  ,     ,   ,        ,   .      .  , ,  ,  :     .    .    ,  ,           .   蠖 ,      ,    ,    .       .   蠖   .   ,    , ,   ,      .

? !




I.    



        ,    ,  ,      .

  ,       ,   ,   ,   .     ,   ,     ,      .   ,    ,    .           .     ,      .      ,        .  ,    ,  ,   ,       ,      .      ( )   ,    . ʠ,   -   .  ,      ,  ,    .

           .    ,     ,       LUV,      II (#litres_trial_promo).           , .          . ,      ,      .      .    ,   ,   ,          . ʠ I       ,     .

Ӡ  ,      ,       ,    ,   ;    .     ,    .



     : ,   ( ,   ,     ,     ).

    ࠖ        ,       .

         ,   - , ,  ,      .



  ,        . Ƞ   (   )    ,    . ,  .




1.    .      ,  


       , ,  ,            ,       ,   .

 .      (1892)

    ,     , ,        , , ,     ,      ,  .      ,  ,       : , , , ,    , 頖    蠖   ,  ,   .      ,  ,   ;  ,    ;  ,     ,   ;     ;   ,  XX.   ,  ,      ,     . ,  ,     XIX,       .

  ,   ,      .          ,  ,  ,     .   XIX.      ,      ,  .   ,   ,       ( : .   (#PUR)).   ,          ,   .      ,        ,  - , , , ,  .  ,      ,     ,    ,     .     1892.       :



   ,          ,       ,   ,      ,     ,    . ,       ,     ,     ,  ,      ,           [25 - Van Pelt G. W. AStudy ofHaigs Uric Acid Theory // Boston Medical andSurgical Journal. 1896. Vol.134. 6. Pp. 129134 // doi.org/10.1056/NEJM189602061340601 (http://doi.org/10.1056/NEJM189602061340601).].


          ,         ,  XX.      . , XXI.,           ,      .        ,     [26 - Johnson R. J. etal. Lessons from Comparative Physiology: Could Uric Acid Represent aPhysiologic Alarm Signal Gone Awry inWestern Society? // Journal ofComparative Physiology B: Biochemical, Systemic, andEnvironmental Physiology. 2009. January. Vol.179. 1. Pp. 6776 // doi.org/10.1007/s00360-008-0291-7 (http://doi.org/10.1007/s00360-008-0291-7).].


 Ƞ :   ?

   ,  ,            ࠖ , .  ,     ,   .       () ,  .    , ,    :    .  ,       .

    ,   :  ,   ,        .     ,        ,    :  ,  ,   ,  ,     .       .

            .        ,   ,     .  ,    ,  ,    , .          ( ),     .  ,     堖    ,        .     ,    ,    ,     .     ,      .       ,          ,      ,         .


 

       (  )      .      ,        .         .   .

     ,    ,         ,      [27 - Framingham Heart Study // framinghamheartstudy.org (http://framinghamheartstudy.org/).].   1948.,     5209    30 62,    .      ,    . Ѡ      ,               ⠖ , ,  ,    .     ,        ,      .

 1999.   ,          ,      ,      [28 - Culleton B. F. etal. Serum Uric Acid andRisk forCardiovascular Disease andDeath: TheFramingham Heart Study // Annals ofInternal Medicine. 1999. July. Vol.131. 1. Pp. 713 // doi.org/10.7326/0003-4819-131-1-199907060-00003 (http://doi.org/10.7326/0003-4819-131-1-199907060-00003).].      ,        .   . ,       ,       , ,   ,        [29 -           scholar.google.com/citations?user=dTgECeMAAAAJ&hl=en (http://scholar.google.com/citations?user%3ddTgECeMAAAAJ%26hl%3den).].    ,  ,            [30 - Johnson R. J., Andrews P. TheFat Gene // Scientific American. 2015. October. Vol.313. 4. Pp. 6469 // doi.org/10.1038/scientificamerican1015-64 (http://doi.org/10.1038/scientificamerican1015-64).].      ,          ,     [31 - Johnson andAndrews. TheFat Gene.].          ,  ,     -      [32 - Johnson andAndrews. TheFat Gene.].

-,        ,    () ,    .  ,     ,    .        .

-,      ,     ,        .       ,         ,     .     ,     堖  ,    ,    .

     ,  ,      ,     ,    [33 - Feig D. I., Soletsky B., Johnson R. J. Effect ofAllopurinol onBlood Pressure ofAdolescents with Newly Diagnosed Essential Hypertension: ARandomized Trial // JAMA. 2008. August. Vol.300. 8. Pp. 924932 // doi.org/10.1001/jama.300.8.924 (http://doi.org/10.1001/jama.300.8.924).]. ʠ , 90%      .       렖 ,       ,     . ,        85% ,      .        JAMA  2008.,            ,   .  ,      ,           -  ,       [34 - Kanbay M. etal. ARandomized Study ofAllopurinol onEndothelial Function andEstimated Glomular Filtration Rate inAsymptomatic Hyperuricemic Subjects with Normal Renal Function // Clinical Journal ofthe American Society ofNephrology. 2011. August. Vol.6. 8. Pp. 18871894 // doi.org/10.2215/CJN.11451210 (http://doi.org/10.2215/CJN.11451210). . George J., Struthers A. D. Role ofUrate, Xanthine Oxidase andthe Effects ofAllopurinol inVascular Oxidative Stress // Vascular Health andRisk Management. 2009. Vol.5. 1. Pp. 265272 // doi.org/10.2147/vhrm.s4265 (http://doi.org/10.2147/vhrm.s4265); Muir S. W. etal. Allopurinol Use Yields Potentially Beneficial Effects onInflammatory Indices inThose with Recent Ischemic Stroke: ARandomized, Double-Blind, Placebo-Controlled Trial // Stroke. 2008. December. Vol.39. 12. Pp. 33033307 // doi.org/10.1161/STROKEAHA.108.519793 (http://doi.org/10.1161/STROKEAHA.108.519793); Dawson J. etal. TheEffect ofAllopurinol onthe Cerebral Vasculature ofPatients with Subcortical Stroke; aRandomized Trial // British Journal ofClinical Pharmacology. 2009. November. Vol.68. 5. Pp. 662668 // doi.org/10.1111/j.13652125.2009.03497.x (http://doi.org/10.1111/j.1365%E2%80%932125.2009.03497.x); Garc?a-Arroyo F. E. etal. Allopurinol Prevents theLipogenic Response Induced byan Acute Oral Fructose Challenge inShort-Term Fructose Fed Rats // Biomolecules. 2019. October. Vol.9. 10. P.601 // doi.org/10.3390/biom9100601 (http://doi.org/10.3390/biom9100601); Singh J. A., Yu Sh. Allopurinol andthe Risk ofStroke inOlder Adults Receiving Medicare // BMC Neurology. 2016. September. Vol.16. 1. P.164 // doi.org/10.1186/s12883-016-0692-2 (http://doi.org/10.1186/s12883-016-0692-2); Bove M. etal. AnEvidence-Based Review onUrate-Lowering Treatments: Implications forOptimal Treatment ofChronic Hyperuricemia // Vascular Health andRisk Management. 2017. February. Vol.13. Pp. 2328 // doi.org/10.2147/VHRM.S115080 (http://doi.org/10.2147/VHRM.S115080).].   ,   -    :          [35 - Piani F., Cicero A. F. G., Borghi C. Uric Acid andHypertension: Prognostic Role andGuide forTreatment // Journal ofClinical Medicine. 2021. January. Vol.10. 3. P.448 // doi.org/10.3390/jcm10030448 (http://doi.org/10.3390/jcm10030448). . Xiong Q., Liu J., Xu Y. Effects ofUric Acid onDiabetes Mellitus andIts Chronic Complications // International Journal ofEndocrinology. 2019. October. Article ID 9691345 // doi.org/10.1155/2019/9691345 (http://doi.org/10.1155/2019/9691345); Gill A. etal. Correlation ofthe Serum Insulin andthe Serum Uric Acid Levels with theGlycated Haemoglobin Levels inthe Patients ofType 2 Diabetes Mellitus // Journal ofClinical andDiagnostic Research. 2013. July. Vol.7. 7. Pp. 12951297 // doi.org/10.7860/JCDR/2013/6017.3121 (http://doi.org/10.7860/JCDR/2013/6017.3121); Soltani Z. etal. Potential Role ofUric Acid inMetabolic Syndrome, Hypertension, Kidney Injury, andCardiovascular Diseases: IsIt Time forReappraisal? // Current Hypertension Reports. 2013. June. Vol.15. 3. Pp. 175181 // doi.org/10.1007/s11906-013-0344-5 (http://doi.org/10.1007/s11906-013-0344-5); Madero M. etal. APilot Study onthe Impact ofa Low Fructose Diet andAllopurinol onClinic Blood Pressure Among Overweight andPrehypertensive Subjects: ARandomized Placebo Controlled Trial // Journal ofthe American Society ofHypertension. 2015. November. Vol.9. 11. Pp. 837844 // doi.org/10.1016/j.jash.2015.07.008 (http://doi.org/10.1016/j.jash.2015.07.008).].

 ,    ,  :  堖   ?  ,       ,  .        :   ,        ,    .     ,    .  ,      ,             .    ,      .          , ,       ,            Homo sapiens.   ,          ,      ,     .      ,    ,    ,     ,     ,    .

   ?  -   ? :       -  ,   ,   ⠫,      [36 - Kratzer J. T. etal. Evolutionary History andMetabolic Insights ofAncient Mammalian Uricases // Proceedings ofthe National Academy ofSciences (USA). 2014. March. Vol.111. 10. Pp. 37633768 // doi.org/10.1073/pnas.1320393111 (http://doi.org/10.1073/pnas.1320393111).].  , ,  ,  , -    ,       .     ,      ,   ,     .   ,    .     .

    :    ,      ,        .       ,     ,          ,       . ,       ,        .    ,  ,   ,            ,    , ,    . :      ,     ,      ,     ,   .        ,      .   ,    .

  ,       .    .  ,  ,      ,  ,  ,     [37 - Rendeiro C. etal. Fructose Decreases Physical Activity andIncreases Body Fat Without Affecting Hippocampal Neurogenesis andLearning Relative toan Isocaloric Glucose Diet // Scientific Reports. 2015. Vol.5. P.9589 // doi.org/10.1038/srep09589 (http://doi.org/10.1038/srep09589). . Beckman Institute forAdvanced Science andTechnology. Fructose Contributes toWeight Gain, Physical Inactivity, andBody Fat, Researchers Find // ScienceDaily, June1, 2015 // sciencedaily.com/releases/2015/06/150601122540.htm (http://sciencedaily.com/releases/2015/06/150601122540.htm).].      :       - ,     ,   ,     .          ,  ,   [38 - Figlewicz D. P. etal. Effect ofModerate Intake ofSweeteners onMetabolic Health inthe Rat // Physiology & Behavior. 2009. December. Vol.98. 5. Pp. 618624 // doi.org/10.1016/j.physbeh.2009.09.016 (http://doi.org/10.1016/j.physbeh.2009.09.016). . Aeberli I. etal. Moderate Amounts ofFructose Consumption Impair Insulin Sensitivity inHealthy Young Men: ARandomized Controlled Trial // Diabetes Care. 2013. January. Vol.36. 1. Pp. 150156 // doi.org/10.2337/dc12-0540 (http://doi.org/10.2337/dc12-0540).].        ,  , ,        ,   ,   ,    .  ,   ,     : ,     .

 2016.            :    .   ,        ,  ,  , ,       [39 - Kanbay M. etal. Uric Acid inMetabolic Syndrome: From anInnocent Bystander toa Central Player // European Journal ofInternal Medicine. 2016. April. Vol.29. Pp. 38 // doi.org/10.1016/j.ejim.2015.11.026 (http://doi.org/10.1016/j.ejim.2015.11.026).].  : -           ,        ,    (   ,  ,  ).      ,   .

    ,     2020.       40 74   ,          [40 - Konta T. etal. Association Between Serum Uric Acid Levels andMortality: ANationwide Community-Based Cohort Study // Scientific Reports. 2020. April. Vol.10. 1. P.6066 // doi.org/10.1038/s41598-020-63134-0 (http://doi.org/10.1038/s41598-020-63134-0).].  ,                   416,5/  297,5/ ;     - .   ,               ,  .  ,      .     ,      ,       327/  ,   .         ,  ,     , ,   .         ,   (      ),  ,     5,5/ . ,          ,       .

     ,     .   ,  8-  16%       ,      ,  , 40%    -   35%  ,    ,   [41 - Chen J.-H. etal. Serum Uric Acid Level asan Independent Risk Factor forAll-Cause, Cardiovascular, andIschemic Stroke Mortality: AChinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol.61. 2. Pp. 225232 // doi.org/10.1002/art.24164 (http://doi.org/10.1002/art.24164).].  ,     :          813%.     :    40   50   35 .       . Ƞ     , ,  ,  ,     ,  ,        .  ,       ,  ,     , ,   ,      .       .

 :     ?  ,  ,         .       .       ,  ,  ,        .      , , ,        ().  頖      ,     [42 - Zhao Y.-C. etal. Nonalcoholic Fatty Liver Disease: AnEmerging Driver ofHypertension // Hypertension. 2020. February. Vol.75. 2. Pp. 275284 // doi.org/10.1161/HYPERTENSIONAHA.119.13419 (http://doi.org/10.1161/HYPERTENSIONAHA.119.13419). . Kasper P. etal. NAFLD andCardiovascular Diseases: AClinical Review // Clinical Research inCardiology. 2021. July. Vol.110. 7. Pp. 921937 // doi.org/10.1007/s00392-020-01709-7 (http://doi.org/10.1007/s00392-020-01709-7).].          2442%,   530%[43 - Younossi Z. M. Non-alcoholic Fatty Liver Disease AGlobal Public Health Perspective // Journal ofHepatology. 2019. March. Vol.70. 3. Pp. 531544 // doi.org/10.1016/j.jhep.2018.10.033 (http://doi.org/10.1016/j.jhep.2018.10.033).]. ,     ,      ,    .

     ,    :      .  ,  ,  ,     -  :        ,        .     Ϡ  , ,    () .         ,   , ,   ,     ,   [44 - Darmawan G., Hamijoyo L., Hasan I. Association Between Serum Uric Acid andNon-alcoholic Fatty Liver Disease: AMeta-Analysis // Acta Medica Indonesiana. 2017. April. Vol.49. 2. Pp. 136147. . Margariti E. etal. Non-alcoholic Fatty Liver Disease May Develop inIndividuals with Normal Body Mass Index // Annals ofGastroenterology. 2012. Vol.25. 1. Pp. 4551; Oral A. etal. Relationship Between Serum Uric Acid Levels andNonalcoholic Fatty Liver Disease inNon-obese Patients // Medicina. 2019. September. Vol.55. 9. P.600 // doi.org/10.3390/medicina55090600 (http://doi.org/10.3390/medicina55090600).].        ,          .  ,      ,            [45 - Paschos P. etal. Can Serum Uric Acid Lowering Therapy Contribute tothe Prevention orTreatment ofNonalcoholic Fatty Liver Disease? // Current Vascular Pharmacology. 2018. Vol.16. 3. Pp. 269275 // doi.org/10.2174/1570161115666170621082237 (http://doi.org/10.2174/1570161115666170621082237).].    .

    頖 .         ,     [46 - Spiga R. etal. Uric Acid IsAssociated with Inflammatory Biomarkers andInduces Inflammation via Activating theNF-?B Signaling Pathway inHepG2 Cells // Arteriosclerosis, Thrombosis, andVascular Biology. 2017. June. Vol.37. 6. Pp. 12411249 // doi.org/10.1161/ATVBAHA.117.309128 (http://doi.org/10.1161/ATVBAHA.117.309128). . Tanaka T. etal. ADouble Blind Placebo Controlled Randomized Trial ofthe Effect ofAcute Uric Acid Changes onInflammatory Markers inHumans: APilot Study // PLOS ONE. 2017. August. Vol.12. 8. P. e0181100 // doi.org/10.1371/journal.pone.0181100 (http://doi.org/10.1371/journal.pone.0181100); Ruggiero C. etal. Uric Acid andInflammatory Markers // European Heart Journal. 2006. May. Vol.27. 10. Pp. 11741181 // doi.org/10.1093/eurheartj/ehi879 (http://doi.org/10.1093/eurheartj/ehi879).].   ,   堖      .    , , ,      ,   .    ,     ,     (   ꠖ    )   (  頖   ).  , ,  ,     ,      ࠖ .     ꠖ      ,  .

23 2004.  Time  ,           [47 - Gorman Ch., Park A., Dell K. Health: TheFires Within // Time. 2004. February23. Vol.163. 8.].           , ,    [48 - Gorman, Park, Dell. Health.].       ,   ,    ,        ,        [49 - Gorman, Park, Dell. Health.].   ,             .  ,    ,           ,   -      :  ,         .         ,    ,        .

    ,        ,  ,     ,    : ,        .    ,   頖    .  ,        ,     ,   , , ,      .        ,         [50 - .      3 2016.  Drperlmutter.com (http://drperlmutter.com/).      . Drdavidludwig.com (http://drdavidludwig.com/).]




  .


   .

   ,     (https://www.litres.ru/pages/biblio_book/?art=68890770)  .

      Visa, MasterCard, Maestro,    ,   ,     ,  PayPal, WebMoney, ., QIWI ,       .



notes








1


    ,  -,         ,  .   ,           .    ,    .        .    ,  ,   DrPerlmutter.com (http://drperlmutter.com/),         .

Peterattiamd.com (http://peterattiamd.com/).




2


         ,              . ..




3


Centers forDisease Control andPrevention (cdc.gov (http://cdc.gov/)); American Heart Association (heart.org (http://heart.org/)).




4


Hidden inPlain Sight // SugarScience, University ofCalifornia atSan Francisco // sugarscience.ucsf.edu/hidden-in-plain-sight/ (http://sugarscience.ucsf.edu/hidden-in-plain-sight/).




5


Haig A. Uric Acid asa Factor inthe Causation ofDisease: AContribution tothe Pathology ofHigh Arterial Tension, Headache, Epilepsy, Mental Depression, Paroxysmal H?moglobinuria andAn?mia, Brights Disease, Diabetes, Gout, Rheumatism, andOther Disorders. London: Franklin Classics, 2018. . Haig A. Uric Acid asa Factor inthe Causation ofDisease AContribution tothe Pathology ofHigh Blood Pressure, Headache, Epilepsy, Mental Depression, Paroxysmal Hemoglobinuria andAnemia, Brights Disease, Gout, Rheumatism andother Disorders // JAMA. 1898. Vol.31. 3. P.139 // doi.org/10.1001/jama.1898.02450030041022 (http://doi.org/10.1001/jama.1898.02450030041022).




6


Fragkou Th., Goula K., Drakoulogkona O. TheHistory ofGout Through Centuries // Nephrology Dialysis Transplantation. 2015. May. Vol.30. Suppl. 3. Pp. iii377iii380 // doi.org/10.1093/ndt/gfv186.05 (http://doi.org/10.1093/ndt/gfv186.05).




7


Oxford English Dictionary, 2nd ed. Oxford, UK: Oxford University Press, 2004.




8


Nuki G., Simkin P. A. AConcise History ofGout andHyperuricemia andTheir Treatment // Arthritis Research & Therapy. 2006. Vol.8. Suppl. 1. P. S1 // doi.org/10.1186/ar1906 (http://doi.org/10.1186/ar1906).




9


Maurer J. Early Gout IsBad forthe Heart: Recent Research Context // Med-Page Today, November28, 2019 // medpagetoday.com/reading-room/acrr/generalrheumatology/83581 (http://medpagetoday.com/reading-room/acrr/generalrheumatology/83581). . Li Y. etal. Clinical Characteristics ofEarly-Onset Gout inOutpatient Setting // ACR Open Rheumatology. 2019. Vol.1. 7. Pp. 397402 // doi.org/10.1002/acr2.11057 (http://doi.org/10.1002/acr2.11057).




10


Singh J. A. Gout: Will theKing ofDiseases Be theFirst Rheumatic Disease toBe Cured? // BMC Medicine. 2016. Vol.14. P.180 // doi.org/10.1186/s12916-016-0732-1 (http://doi.org/10.1186/s12916-016-0732-1).




11


George Ch., Minter D. A. Hyperuricemia // StatPearls. Treasure Island, FL: 2021 // ncbi.nlm.nih.gov/books/NBK459218/ (http://ncbi.nlm.nih.gov/books/NBK459218/).




12


Chen J.-H. etal. Serum Uric Acid Level asan Independent Risk Factor forAll-Cause, Cardiovascular, andIschemic Stroke Mortality: AChinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol.61. 2. Pp. 225232 // doi.org/10.1002/art.24164 (http://doi.org/10.1002/art.24164). . Prado de Oliveira E., Burini R. C. High Plasma Uric Acid Concentration: Causes andConsequences // Diabetology & Metabolic Syndrome. 2012. April. Vol.4. P.12 // doi.org/10.1186/1758-5996-4-12 (http://doi.org/10.1186/1758-5996-4-12).




13


El Ridi R., Tallima H. Physiological Functions andPathogenic Potential ofUric Acid: AReview // Journal ofAdvanced Research. 2017. September. Vol.8. 5. Pp. 487493 // doi.org/10.1016/j.jare.2017.03.003 (http://doi.org/10.1016/j.jare.2017.03.003).




14


El Ridi andTallima, Physiological Functions andPathogenic Potential ofUric Acid.




15


DiNicolantonio J. J., OKeefe J. H., Lucan S. C. Added Fructose: APrincipal Driver ofType 2 Diabetes Mellitus andIts Consequences // Mayo Clinic Proceedings. 2015. March. Vol.90. 3. Pp. 372381 // doi.org/10.1016/j.mayocp.2014.12.019 (http://doi.org/10.1016/j.mayocp.2014.12.019).




16


Stirpe F. etal. Fructose-induced Hyperuricaemia // TheLancet. 1970. December. Vol.296. 7686. Pp. 13101311 // doi.org/10.1016/s0140-6736(70)92269-5 (http://doi.org/10.1016/s0140-6736%2870%2992269-5).




17


Goran M. I. etal. TheObesogenic Effect ofHigh Fructose Exposure During Early Development // Nature Reviews Endocrinology. 2013. August. Vol.9. 8. Pp. 494500.




18


Rivard Ch. etal. Sack andSugar, andthe Aetiology ofGout inEngland Between 1650 and1900 // Rheumatology. 2013. March. Vol.52. 3. Pp. 421426 // doi.org/10.1093/rheumatology/kes297 (http://doi.org/10.1093/rheumatology/kes297).




19


Zgaga L. etal. TheAssociation ofDietary Intake ofPurine-Rich Vegetables, Sugar-Sweetened Beverages andDairy with Plasma Urate, ina Cross-Sectional Study // PLOS ONE. 2012. Vol.7. 6. P. e38123 // doi.org/10.1371/journal.pone.0038123 (http://doi.org/10.1371/journal.pone.0038123).




20


Singh J. A., Reddy S. G., Kundukulam J. Risk Factors forGout andPrevention: ASystematic Review ofthe Literature // Current Opinion inRheumatology. 2011. March. Vol.23. 2. Pp. 192202 // doi.org/10.1097/BOR.0b013e3283438e13 (http://doi.org/10.1097/BOR.0b013e3283438e13).




21


LUV    love (). ..




22


 , ,     , . ..




23


Enzinger Ch. etal. Risk Factors forProgression ofBrain Atrophy inAging: Six-Year Follow-Up ofNormal Subjects // Neurology. 2005. May24. Vol.64. 10. Pp. 17041711 // doi.org/10.1212/01.WNL.0000161871.83614.BB (http://doi.org/10.1212/01.WNL.0000161871.83614.BB).




24


Crane P. K. etal. Glucose Levels andRisk ofDementia // New England Journal ofMedicine. 2013. August. Vol.369. 6. Pp. 540548 // doi.org/10.1056/NEJMoa1215740 (http://doi.org/10.1056/NEJMoa1215740).




25


Van Pelt G. W. AStudy ofHaigs Uric Acid Theory // Boston Medical andSurgical Journal. 1896. Vol.134. 6. Pp. 129134 // doi.org/10.1056/NEJM189602061340601 (http://doi.org/10.1056/NEJM189602061340601).




26


Johnson R. J. etal. Lessons from Comparative Physiology: Could Uric Acid Represent aPhysiologic Alarm Signal Gone Awry inWestern Society? // Journal ofComparative Physiology B: Biochemical, Systemic, andEnvironmental Physiology. 2009. January. Vol.179. 1. Pp. 6776 // doi.org/10.1007/s00360-008-0291-7 (http://doi.org/10.1007/s00360-008-0291-7).




27


Framingham Heart Study // framinghamheartstudy.org (http://framinghamheartstudy.org/).




28


Culleton B. F. etal. Serum Uric Acid andRisk forCardiovascular Disease andDeath: TheFramingham Heart Study // Annals ofInternal Medicine. 1999. July. Vol.131. 1. Pp. 713 // doi.org/10.7326/0003-4819-131-1-199907060-00003 (http://doi.org/10.7326/0003-4819-131-1-199907060-00003).




29


          scholar.google.com/citations?user=dTgECeMAAAAJ&hl=en (http://scholar.google.com/citations?user%3ddTgECeMAAAAJ%26hl%3den).




30


Johnson R. J., Andrews P. TheFat Gene // Scientific American. 2015. October. Vol.313. 4. Pp. 6469 // doi.org/10.1038/scientificamerican1015-64 (http://doi.org/10.1038/scientificamerican1015-64).




31


Johnson andAndrews. TheFat Gene.




32


Johnson andAndrews. TheFat Gene.




33


Feig D. I., Soletsky B., Johnson R. J. Effect ofAllopurinol onBlood Pressure ofAdolescents with Newly Diagnosed Essential Hypertension: ARandomized Trial // JAMA. 2008. August. Vol.300. 8. Pp. 924932 // doi.org/10.1001/jama.300.8.924 (http://doi.org/10.1001/jama.300.8.924).




34


Kanbay M. etal. ARandomized Study ofAllopurinol onEndothelial Function andEstimated Glomular Filtration Rate inAsymptomatic Hyperuricemic Subjects with Normal Renal Function // Clinical Journal ofthe American Society ofNephrology. 2011. August. Vol.6. 8. Pp. 18871894 // doi.org/10.2215/CJN.11451210 (http://doi.org/10.2215/CJN.11451210). . George J., Struthers A. D. Role ofUrate, Xanthine Oxidase andthe Effects ofAllopurinol inVascular Oxidative Stress // Vascular Health andRisk Management. 2009. Vol.5. 1. Pp. 265272 // doi.org/10.2147/vhrm.s4265 (http://doi.org/10.2147/vhrm.s4265); Muir S. W. etal. Allopurinol Use Yields Potentially Beneficial Effects onInflammatory Indices inThose with Recent Ischemic Stroke: ARandomized, Double-Blind, Placebo-Controlled Trial // Stroke. 2008. December. Vol.39. 12. Pp. 33033307 // doi.org/10.1161/STROKEAHA.108.519793 (http://doi.org/10.1161/STROKEAHA.108.519793); Dawson J. etal. TheEffect ofAllopurinol onthe Cerebral Vasculature ofPatients with Subcortical Stroke; aRandomized Trial // British Journal ofClinical Pharmacology. 2009. November. Vol.68. 5. Pp. 662668 // doi.org/10.1111/j.13652125.2009.03497.x (http://doi.org/10.1111/j.1365%E2%80%932125.2009.03497.x); Garc?a-Arroyo F. E. etal. Allopurinol Prevents theLipogenic Response Induced byan Acute Oral Fructose Challenge inShort-Term Fructose Fed Rats // Biomolecules. 2019. October. Vol.9. 10. P.601 // doi.org/10.3390/biom9100601 (http://doi.org/10.3390/biom9100601); Singh J. A., Yu Sh. Allopurinol andthe Risk ofStroke inOlder Adults Receiving Medicare // BMC Neurology. 2016. September. Vol.16. 1. P.164 // doi.org/10.1186/s12883-016-0692-2 (http://doi.org/10.1186/s12883-016-0692-2); Bove M. etal. AnEvidence-Based Review onUrate-Lowering Treatments: Implications forOptimal Treatment ofChronic Hyperuricemia // Vascular Health andRisk Management. 2017. February. Vol.13. Pp. 2328 // doi.org/10.2147/VHRM.S115080 (http://doi.org/10.2147/VHRM.S115080).




35


Piani F., Cicero A. F. G., Borghi C. Uric Acid andHypertension: Prognostic Role andGuide forTreatment // Journal ofClinical Medicine. 2021. January. Vol.10. 3. P.448 // doi.org/10.3390/jcm10030448 (http://doi.org/10.3390/jcm10030448). . Xiong Q., Liu J., Xu Y. Effects ofUric Acid onDiabetes Mellitus andIts Chronic Complications // International Journal ofEndocrinology. 2019. October. Article ID 9691345 // doi.org/10.1155/2019/9691345 (http://doi.org/10.1155/2019/9691345); Gill A. etal. Correlation ofthe Serum Insulin andthe Serum Uric Acid Levels with theGlycated Haemoglobin Levels inthe Patients ofType 2 Diabetes Mellitus // Journal ofClinical andDiagnostic Research. 2013. July. Vol.7. 7. Pp. 12951297 // doi.org/10.7860/JCDR/2013/6017.3121 (http://doi.org/10.7860/JCDR/2013/6017.3121); Soltani Z. etal. Potential Role ofUric Acid inMetabolic Syndrome, Hypertension, Kidney Injury, andCardiovascular Diseases: IsIt Time forReappraisal? // Current Hypertension Reports. 2013. June. Vol.15. 3. Pp. 175181 // doi.org/10.1007/s11906-013-0344-5 (http://doi.org/10.1007/s11906-013-0344-5); Madero M. etal. APilot Study onthe Impact ofa Low Fructose Diet andAllopurinol onClinic Blood Pressure Among Overweight andPrehypertensive Subjects: ARandomized Placebo Controlled Trial // Journal ofthe American Society ofHypertension. 2015. November. Vol.9. 11. Pp. 837844 // doi.org/10.1016/j.jash.2015.07.008 (http://doi.org/10.1016/j.jash.2015.07.008).




36


Kratzer J. T. etal. Evolutionary History andMetabolic Insights ofAncient Mammalian Uricases // Proceedings ofthe National Academy ofSciences (USA). 2014. March. Vol.111. 10. Pp. 37633768 // doi.org/10.1073/pnas.1320393111 (http://doi.org/10.1073/pnas.1320393111).




37


Rendeiro C. etal. Fructose Decreases Physical Activity andIncreases Body Fat Without Affecting Hippocampal Neurogenesis andLearning Relative toan Isocaloric Glucose Diet // Scientific Reports. 2015. Vol.5. P.9589 // doi.org/10.1038/srep09589 (http://doi.org/10.1038/srep09589). . Beckman Institute forAdvanced Science andTechnology. Fructose Contributes toWeight Gain, Physical Inactivity, andBody Fat, Researchers Find // ScienceDaily, June1, 2015 // sciencedaily.com/releases/2015/06/150601122540.htm (http://sciencedaily.com/releases/2015/06/150601122540.htm).




38


Figlewicz D. P. etal. Effect ofModerate Intake ofSweeteners onMetabolic Health inthe Rat // Physiology & Behavior. 2009. December. Vol.98. 5. Pp. 618624 // doi.org/10.1016/j.physbeh.2009.09.016 (http://doi.org/10.1016/j.physbeh.2009.09.016). . Aeberli I. etal. Moderate Amounts ofFructose Consumption Impair Insulin Sensitivity inHealthy Young Men: ARandomized Controlled Trial // Diabetes Care. 2013. January. Vol.36. 1. Pp. 150156 // doi.org/10.2337/dc12-0540 (http://doi.org/10.2337/dc12-0540).




39


Kanbay M. etal. Uric Acid inMetabolic Syndrome: From anInnocent Bystander toa Central Player // European Journal ofInternal Medicine. 2016. April. Vol.29. Pp. 38 // doi.org/10.1016/j.ejim.2015.11.026 (http://doi.org/10.1016/j.ejim.2015.11.026).




40


Konta T. etal. Association Between Serum Uric Acid Levels andMortality: ANationwide Community-Based Cohort Study // Scientific Reports. 2020. April. Vol.10. 1. P.6066 // doi.org/10.1038/s41598-020-63134-0 (http://doi.org/10.1038/s41598-020-63134-0).




41


Chen J.-H. etal. Serum Uric Acid Level asan Independent Risk Factor forAll-Cause, Cardiovascular, andIschemic Stroke Mortality: AChinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol.61. 2. Pp. 225232 // doi.org/10.1002/art.24164 (http://doi.org/10.1002/art.24164).




42


Zhao Y.-C. etal. Nonalcoholic Fatty Liver Disease: AnEmerging Driver ofHypertension // Hypertension. 2020. February. Vol.75. 2. Pp. 275284 // doi.org/10.1161/HYPERTENSIONAHA.119.13419 (http://doi.org/10.1161/HYPERTENSIONAHA.119.13419). . Kasper P. etal. NAFLD andCardiovascular Diseases: AClinical Review // Clinical Research inCardiology. 2021. July. Vol.110. 7. Pp. 921937 // doi.org/10.1007/s00392-020-01709-7 (http://doi.org/10.1007/s00392-020-01709-7).




43


Younossi Z. M. Non-alcoholic Fatty Liver Disease AGlobal Public Health Perspective // Journal ofHepatology. 2019. March. Vol.70. 3. Pp. 531544 // doi.org/10.1016/j.jhep.2018.10.033 (http://doi.org/10.1016/j.jhep.2018.10.033).




44


Darmawan G., Hamijoyo L., Hasan I. Association Between Serum Uric Acid andNon-alcoholic Fatty Liver Disease: AMeta-Analysis // Acta Medica Indonesiana. 2017. April. Vol.49. 2. Pp. 136147. . Margariti E. etal. Non-alcoholic Fatty Liver Disease May Develop inIndividuals with Normal Body Mass Index // Annals ofGastroenterology. 2012. Vol.25. 1. Pp. 4551; Oral A. etal. Relationship Between Serum Uric Acid Levels andNonalcoholic Fatty Liver Disease inNon-obese Patients // Medicina. 2019. September. Vol.55. 9. P.600 // doi.org/10.3390/medicina55090600 (http://doi.org/10.3390/medicina55090600).




45


Paschos P. etal. Can Serum Uric Acid Lowering Therapy Contribute tothe Prevention orTreatment ofNonalcoholic Fatty Liver Disease? // Current Vascular Pharmacology. 2018. Vol.16. 3. Pp. 269275 // doi.org/10.2174/1570161115666170621082237 (http://doi.org/10.2174/1570161115666170621082237).




46


Spiga R. etal. Uric Acid IsAssociated with Inflammatory Biomarkers andInduces Inflammation via Activating theNF-?B Signaling Pathway inHepG2 Cells // Arteriosclerosis, Thrombosis, andVascular Biology. 2017. June. Vol.37. 6. Pp. 12411249 // doi.org/10.1161/ATVBAHA.117.309128 (http://doi.org/10.1161/ATVBAHA.117.309128). . Tanaka T. etal. ADouble Blind Placebo Controlled Randomized Trial ofthe Effect ofAcute Uric Acid Changes onInflammatory Markers inHumans: APilot Study // PLOS ONE. 2017. August. Vol.12. 8. P. e0181100 // doi.org/10.1371/journal.pone.0181100 (http://doi.org/10.1371/journal.pone.0181100); Ruggiero C. etal. Uric Acid andInflammatory Markers // European Heart Journal. 2006. May. Vol.27. 10. Pp. 11741181 // doi.org/10.1093/eurheartj/ehi879 (http://doi.org/10.1093/eurheartj/ehi879).




47


Gorman Ch., Park A., Dell K. Health: TheFires Within // Time. 2004. February23. Vol.163. 8.




48


Gorman, Park, Dell. Health.




49


Gorman, Park, Dell. Health.




50


.      3 2016.  Drperlmutter.com (http://drperlmutter.com/).      . Drdavidludwig.com (http://drdavidludwig.com/).


